Simonov A N, Klyushnik T P, Androsova L V, Mikhailova N M
Mental Health Research Center, Moscow, Russia.
Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(12):40-43. doi: 10.17116/jnevro201811812140.
The evaluation of the risk of Alzheimer disease (AD) in patients with cognitive impairment, amnestic type (aMCI) on the basis of cluster analysis and logistic regression with the use of such markers of inflammation as enzymatic activity of leukocyte elastase (LE) and the functional activity of α1-proteinase inhibitor (α1-PI).
The study object of statistical analysis was the database, including the results of LE activity and functional α1-PI activity in blood plasma of 78 outpatients with aMCI (25 men and 53 women, aged 44 to 89 years (69.1±9.95).
Clustering by k-means and classification by logistic regression indicate a high probability of AD in patients with aMCI depending on the activity of LE and α1-PI in blood plasma. The total coincidence of objects included in the clusters and in the AD risk group was 94%. The high coincidence of two different methods of grouping confirms the previously stated notion of the possibility of identifying patients with the high risk of AD among patients with aMCI by the activity of LE and α1-PI in the blood.
基于聚类分析和逻辑回归,利用白细胞弹性蛋白酶(LE)的酶活性和α1-蛋白酶抑制剂(α1-PI)的功能活性等炎症标志物,评估遗忘型轻度认知障碍(aMCI)患者患阿尔茨海默病(AD)的风险。
统计分析的研究对象是一个数据库,其中包含78例aMCI门诊患者血浆中LE活性和功能性α1-PI活性的检测结果(25名男性和53名女性,年龄44至89岁(69.1±9.95))。
通过k均值聚类和逻辑回归分类表明,根据血浆中LE和α1-PI的活性,aMCI患者患AD的可能性很高。聚类中包含的对象与AD风险组中的对象总符合率为94%。两种不同分组方法的高符合率证实了之前提出的观点,即通过血液中LE和α1-PI的活性可以在aMCI患者中识别出患AD高风险的患者。